Literature DB >> 2670562

Activation of c-myb by carboxy-terminal truncation: relationship to transformation of murine haemopoietic cells in vitro.

T J Gonda1, C Buckmaster, R G Ramsay.   

Abstract

Murine retroviruses which encode c-myb proteins that have either complete or truncated carboxy (C) termini were used to infect haemopoietic cells from murine fetal liver. Using an agar colony assay, we could show that infection with the virus encoding the truncated protein resulted in the persistence of colony-forming cells well beyond the short period for which such cells are present in uninfected cultures. The resultant colonies failed to give rise to cell lines; however, clonal cell lines occasionally emerged from the original infected liquid cultures. The virus which encoded a myb protein with a complete C-terminus was virtually inactive in the colony assay; surprisingly, however, this virus could enhance proliferation in liquid cultures and has led to the generation of at least one cell line. In addition to demonstrating 'activation' of c-myb by C-terminal truncation, our results imply that an unaltered c-myb protein can also contribute to cellular transformation and that a second event is required to establish myb-transformed cells as a permanent cell line.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670562      PMCID: PMC401022          DOI: 10.1002/j.1460-2075.1989.tb03571.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  Focus assay and defectiveness of avian myeloblastosis virus.

Authors:  C Moscovici; L Gazzolo; M G Moscovici
Journal:  Virology       Date:  1975-11       Impact factor: 3.616

2.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

3.  Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses.

Authors:  T Graf; A von Kirchbach; H Beug
Journal:  Exp Cell Res       Date:  1981-02       Impact factor: 3.905

4.  Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene.

Authors:  K H Klempnauer; T J Gonda; J M Bishop
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene.

Authors:  K Radke; H Beug; S Kornfeld; T Graf
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

7.  Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia.

Authors:  P G Pelicci; L Lanfrancone; M D Brathwaite; S R Wolman; R Dalla-Favera
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  Introduction of a human colony stimulating factor-1 gene into a mouse macrophage cell line induces CSF-1 independence but not tumorigenicity.

Authors:  M F Roussel; C W Rettenmier; C J Sherr
Journal:  Blood       Date:  1988-05       Impact factor: 22.113

9.  The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb.

Authors:  K H Klempnauer; G Ramsay; J M Bishop; M G Moscovici; C Moscovici; J P McGrath; A D Levinson
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

10.  Growth of factor-dependent hemopoietic precursor cell lines.

Authors:  T M Dexter; J Garland; D Scott; E Scolnick; D Metcalf
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  30 in total

1.  The chromatin remodeling complex NoRC and TTF-I cooperate in the regulation of the mammalian rRNA genes in vivo.

Authors:  Attila Németh; Ralf Strohner; Ingrid Grummt; Gernot Längst
Journal:  Nucleic Acids Res       Date:  2004-08-03       Impact factor: 16.971

2.  Protein truncation is required for the activation of the c-myb proto-oncogene.

Authors:  F A Grässer; T Graf; J S Lipsick
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Reduction of a conserved Cys is essential for Myb DNA-binding.

Authors:  S Guehmann; G Vorbrueggen; F Kalkbrenner; K Moelling
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

4.  Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm.

Authors:  K Suzuki; Y Suzuki; A Hama; H Muramatsu; M Nakatochi; M Gunji; D Ichikawa; M Hamada; R Taniguchi; S Kataoka; N Murakami; D Kojima; Y Sekiya; E Nishikawa; N Kawashima; A Narita; N Nishio; Y Nakazawa; H Iwafuchi; K-I Watanabe; Y Takahashi; M Ito; S Kojima; S Kato; Y Okuno
Journal:  Leukemia       Date:  2017-03-27       Impact factor: 11.528

5.  Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

Authors:  Annika K Wefers; Damian Stichel; Daniel Schrimpf; Roland Coras; Mélanie Pages; Arnault Tauziède-Espariat; Pascale Varlet; Daniel Schwarz; Figen Söylemezoglu; Ute Pohl; José Pimentel; Jochen Meyer; Ekkehard Hewer; Anna Japp; Abhijit Joshi; David E Reuss; Annekathrin Reinhardt; Philipp Sievers; M Belén Casalini; Azadeh Ebrahimi; Kristin Huang; Christian Koelsche; Hu Liang Low; Olinda Rebelo; Dina Marnoto; Albert J Becker; Ori Staszewski; Michel Mittelbronn; Martin Hasselblatt; Jens Schittenhelm; Edmund Cheesman; Ricardo Santos de Oliveira; Rosane Gomes P Queiroz; Elvis Terci Valera; Volkmar H Hans; Andrey Korshunov; Adriana Olar; Keith L Ligon; Stefan M Pfister; Zane Jaunmuktane; Sebastian Brandner; Ruth G Tatevossian; David W Ellison; Thomas S Jacques; Mrinalini Honavar; Eleonora Aronica; Maria Thom; Felix Sahm; Andreas von Deimling; David T W Jones; Ingmar Blumcke; David Capper
Journal:  Acta Neuropathol       Date:  2019-09-28       Impact factor: 17.088

6.  FAETL motif required for leukemic transformation by v-Myb.

Authors:  S L Fu; J S Lipsick
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Functional analysis of carboxy-terminal deletion mutants of c-Myb.

Authors:  D M Wang; J W Dubendorff; C H Woo; J S Lipsick
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.

Authors:  A E Cuddihy; L A Brents; N Aziz; T P Bender; W M Kuehl
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Individual repeats of Drosophila Myb can function in transformation by v-Myb.

Authors:  X Bin; J S Lipsick
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  The carboxyterminus of human c-myb protein stimulates activated transcription in trans.

Authors:  G Vorbrueggen; F Kalkbrenner; S Guehmann; K Moelling
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.